A double blind randomised placebo controlled phase III trial in patients with chronic idiopathic constipation to demonstrate the efficacy and safety of Elobixibat 5mgs & 10mgs for 26 wks (ECHO)
1st September 2013
Status: Ended
Specialism: Lower GI.
Team: Professor Robin Spiller.
People
| Photo | Name | Bio |
|---|---|---|
 |
Professor Robin Spiller | Professor Spiller is Professor of Gastroenterology in the NIHR Nottingham Biomedical Research Centre at the University of Nottingham. Past Editor of Gut (2003-2009) and member of the Board of the Rome Foundation (2000-2015), he twice edited the… |
Publications
| Title |
|---|
Grants
| Title | Amount |
|---|
